Carole Lunny, PhD

Rockies climbing trip lay week! Temperatures were hot so we did shaded multipitches

👇👇

Climbed on limestone in Marble Canyon, BC this weekend. 8 pitches of approximately 30 metres on a climb called Stone Marmot, 10a

Screenshot of a DM The National Library of Medicine (NLM) will undergo a “realignment” effective July 1. With 40% of staff positions eliminated, the remaining staff and services will focus on core library functions, including Collection Development and Health Data Standards (formerly Bibliographic Services). NCBI will continue operations but with reduced staff and services. Outreach will no longer be considered a core function. The Branch, which oversees NNLM, will be dissolved. NNLM will continue under the Office of Strategic Operations Traveling Exhibits and History Talks are suspended. Exhibits already on loan or scheduled will proceed, but no new programs or outreach initiatives will be offered. No new website curations will be created. MedlinePlus will be maintained as needed, but no new content will be developed.

Sharing this update provided to me directly about the state of NLM and the future of NNLM, traveling exhibits, and, somehow, MedlinePlus.

I am so worried for friends and colleagues, and I'm stuck on that, but it is hard to not want to scream WTF about a MedlinePlus with no new material.

#medlibs

It will become generic in Canada in Q1 of 2026

Novo Nordisk's Canadian Mistake

Apparently Ozempics patent fee was not paid by Novo (in error) and it will become generic in Q1 of 2026. In the US it will be 2032 before Ozempic’s patent protection lapses. Canada is the second-largest Ozempic market globally, due to cross-border buying
www.science.org/content/blog...

You're a trad climber! How was it? I climbed in Scotland but it wasn't the greatest (but I love in Squamish, BC, so there's that 😊)

How ‘correct’ should #evidencesynthesis be? How does this change if we add #AI?

Help inform new tool dev and best practice guidance! forms.office.com/e/ZwdicYQpjv

Open until 2 Jul, ~35 mins. Part of @wellcometrust.bsky.social funded DESTinY @campbellreviews.bsky.social @ellaflem.bsky.social

Ahoy! Read more about the benefits of trial registration in my article by Kay Dickersin and Iain Chalmers, including their discussion of John Simes' 1986 call for an international registry of clinical trials
www.jameslindlibrary.org/articles/rec...
Simes 1986: www.jameslindlibrary.org/simes-rj-1986/

Poilievre’s been on the public payroll since he was 24—with the biggest taxpayer-funded pension in history coming his way. But he calls CBC “government funded” like it’s a smear? That’s not accountability. That’s hypocrisy.

#SaveTheCBC #PoilievreExposed #CdnPoli

Just got back from a rock climbing trip to sunny Shaka Bluffs, Penticton, BC, Canada #rockclimbing #skaha #climbing

During my time at the KT program as a postdoc, I was sooo appreciative of all the support I got, from my amazing supervisor Dr Tricco, to RAs and support staff. Thanks for all the love!

Sweet, thanks Hilda for the shout out!

Approximately 1 in 7 Scientific Papers Are Fake

@metaror.bsky.social cuts out the publishers, providing open peer review, with a brief editorial summing up. Two recent examples are reviews (metaror.org/kotahi/artic...) of @jamesheathers.bsky.social's piece estimating 1/7 papers are fake and

Thanks for the shout out!

Can umbrella reviews be automated with AI? I am positive it can be done! See: The Umbrella Collaboration®: An Innovative Tertiary Evidence Synthesis Methodology. Validation Study Protocol, by Carrillo et al doi.org/10.2196/prep...

Risk of Bias in Network Meta-Analysis (RoB NMA) tool Systematic reviews with network meta-analysis (NMA) have potential biases in their conduct, analysis, and interpretation. If the results or conclusions of an NMA are integrated into policy or practice...

A new study from St. Michael's researchers provides guidance on the RoB NMA tool. The RoB NMA tool helps assess bias in network meta-analyses of healthcare interventions. Learn more in @bmj.com: www.bmj.com/content/388/... #UnityHealthResearch

Here is a look at the overall bias assessment

6/ For those who spend much of their time on systematic reviews, health technology assessment (HTA), evidence synthesis, or reimbursement decision-making, we hope you find this tool to be valuable!

What are your thoughts on improving the evaluation of NMAs? Share freely in the comments below

Risk of Bias in Network Meta-Analysis (RoB NMA) tool Systematic reviews with network meta-analysis (NMA) have potential biases in their conduct, analysis, and interpretation. If the results or conclusions of an NMA are integrated into policy or practice...

5/ A systematic framework for assessing whether bias could affect NMA conclusions.

Read the full article here: www.bmj.com/content/388/...

4/ ➡️ For policymakers & guideline developers: Provides confidence that NMA-based recommendations are built on trustworthy evidence

What's in the Paper?
A multi-item tool covering key sources of bias in NMAs

Practical guidance on applying the tool, with real-world examples

3/ How this tool can help:
➡️For researchers: Ensures methodological rigor when conducting and appraising NMAs
➡️For HTA professionals & market access teams: Supports robust evidence evaluation for
reimbursement and coverage decisions

2/ It was a pleasure to be the lead researcher of an international team to develop the ROB NMA tool, published in The BMJ. This tool provides a structured, transparent approach for assessing the risk of bias in NMAS, filling a key gap in the evaluation of comparative effectiveness research

1/ Proud to announce our 4 year project to develop a risk of bias tool for network meta-analyses is complete, called the Risk of bias in Network Meta-analysis (RoB NMA) tool

Systematic reviews with network meta-analyses (NMAs) are a type of synthesis that combines studies on the exact same topic